VIYASH259.00

Viyash Scientific Ltd.

· Pharma & Health
₹ CrorePeersAARTIDRUGSYATHARTHTHYROCARESUPRIYASTARSPARCSHILPAMEDRUBICONMcap ₹11,314 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment248.6231.61,137.91,137.9
+ Capital Work-in-Progress11.115.168.768.7
+ Goodwill234.9248.8868.7868.7
+ Other Intangibles56.9105.696.396.3
+ Intangibles under Development4.90.61.71.7
+ Non-current Investments0.90.00.00.0
+ Other Non-current Financial Assets12.310.522.222.2
Non-current Financial Assets13.210.522.222.2
+ Deferred Tax Assets78.4102.783.483.4
+ Other Non-current Assets69.613.394.994.9
Total Non-current Assets717.5728.22,373.82,373.8
Current Assets
+ Inventories346.2385.3803.2803.2
+ Current Investments2.60.10.10.1
+ Trade Receivables335.6363.21,045.21,045.2
+ Cash & Cash Equivalents64.862.7255.8255.8
+ Other Bank Balances5.06.414.014.0
+ Short-term Loans0.10.20.10.1
+ Other Current Financial Assets1.91.12.02.0
Current Financial Assets410.1433.61,317.11,317.1
+ Other Current Assets54.253.7129.5129.5
Total Current Assets810.9872.92,254.62,254.6
Total Assets1,540.41,602.04,628.44,628.4
Equity
+ Equity Share Capital49.950.187.487.4
+ Other Equity / Reserves606.7654.42,823.72,823.7
Equity — Owners of Parent656.6704.52,911.12,911.1
+ Minority Interest56.465.9203.7203.7
Total Equity713.0770.43,114.73,114.7
Liabilities
+ Borrowings — Non-current142.7273.9302.1302.1
+ Other Non-current Financial Liab29.126.339.539.5
Non-current Financial Liabilities171.8300.2341.6341.6
+ Provisions — Non-current21.722.740.340.3
+ Deferred Tax Liabilities6.93.732.832.8
+ Other Non-current Liabilities0.00.0153.1153.1
Non-current Liabilities200.4326.6567.8567.8
+ Borrowings — Current308.6172.5133.7133.7
+ Trade Payables260.3256.7597.3597.3
+ Other Current Financial Liab12.932.3105.4105.4
Current Financial Liabilities581.8461.5836.4836.4
+ Provisions — Current8.07.615.715.7
+ Current Tax Liabilities3.311.924.124.1
+ Other Current Liabilities33.924.169.769.7
Current Liabilities627.0505.0945.9945.9
Total Liabilities827.4831.61,513.71,513.7
Total Equity & Liabilities1,540.41,602.04,628.44,628.4
Assets — additional as-filed lines
+ Non-current Assets Held for Sale11.90.80.00.0
+ Current Tax Assets0.40.34.74.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current0.036.236.2
+ Dues to Other Creditors — Current256.7561.1561.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.